Tag: Investigational New Drug Application
August 22, 2019
Seelos Therapeutics Receives IND Application Approval for SLS-005
Seelos Therapeutics (NASDAQ:SEEL) has announced that the US Food and Drug Administration (FDA) has accepted its Investigational New Drug Application... August 14, 2019
Zosano Pharma Files IND for a Phase 2/3 Clinical Study in Cluster Headache
Zosano Pharma (NASDAQ:ZSAN) has announced it has filed an investigational new drug application to the US Food and Drug Administration... August 12, 2019
ProQR Receives IND Clearance to Start Clinical Trial of QR-1123
ProQR Therapeutics (NASDAQ:PRQR) has announced that the US Food and Drug Administration (FDA) has cleared the company’s investigational new drug... July 19, 2019
Ascendis Pharma Files Investigational New Drug Application for Phase 2 Trial of TransCon
Ascendis Pharma (NASDAQ:ASND) has announced it has filed an investigational new drug application with the US Food and Drug Administration... June 25, 2019
Arvinas Authorized to Proceed with ARV-471
Arvinas (NASDAQ:ARVN) has announced that the US Food and Drug Administration (FDA) has authorized the company’s investigational new drug application... June 18, 2019
CymaBay Therapeutics Announces IND to Commence a Clinical Study of Seladelpar
CymaBay Therapeutics (NASDAQ:CBAY) has announced that the US Food and Drug Administration (FDA) has cleared the company’s investigational new drug... May 16, 2019